BE889182A - Procede de preparation de mutants nouveaux de virus d'herpes simplex type 1 ou type 2, virus mutants ainsi obtenus, vaccins prepares a partir de ceux-ci, procede pour la preparation de tels vaccins et utilisations therapeutiques et pharmacologiques - Google Patents
Procede de preparation de mutants nouveaux de virus d'herpes simplex type 1 ou type 2, virus mutants ainsi obtenus, vaccins prepares a partir de ceux-ci, procede pour la preparation de tels vaccins et utilisations therapeutiques et pharmacologiquesInfo
- Publication number
- BE889182A BE889182A BE6/47470A BE6047470A BE889182A BE 889182 A BE889182 A BE 889182A BE 6/47470 A BE6/47470 A BE 6/47470A BE 6047470 A BE6047470 A BE 6047470A BE 889182 A BE889182 A BE 889182A
- Authority
- BE
- Belgium
- Prior art keywords
- preparation
- vaccines
- type
- viruses
- therapeutic
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title 2
- 238000000034 method Methods 0.000 title 2
- 238000002360 preparation method Methods 0.000 title 2
- 230000008569 process Effects 0.000 title 2
- 229960005486 vaccine Drugs 0.000 title 2
- 230000000144 pharmacologic effect Effects 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16661—Methods of inactivation or attenuation
- C12N2710/16663—Methods of inactivation or attenuation by chemical treatment
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8019308 | 1980-06-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE889182A true BE889182A (fr) | 1981-12-11 |
Family
ID=10514018
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE6/47470A BE889182A (fr) | 1980-06-12 | 1981-06-11 | Procede de preparation de mutants nouveaux de virus d'herpes simplex type 1 ou type 2, virus mutants ainsi obtenus, vaccins prepares a partir de ceux-ci, procede pour la preparation de tels vaccins et utilisations therapeutiques et pharmacologiques |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4322404A (fr) |
| BE (1) | BE889182A (fr) |
| DE (1) | DE3122669A1 (fr) |
| ES (1) | ES502965A0 (fr) |
| FR (1) | FR2484446A1 (fr) |
| IT (1) | IT8148649A0 (fr) |
| NL (1) | NL8102827A (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4554159A (en) * | 1981-11-12 | 1985-11-19 | Institute Merieux | Vaccine and method of immunizing against herpes simplex virus (types 1 and 2) |
| GB8305323D0 (en) * | 1983-02-25 | 1983-03-30 | Baylor College Medicine | Infectious bovine rhinotracheitis vaccine |
| NL8303501A (nl) * | 1983-10-12 | 1985-05-01 | Centraal Diergeneeskundig Inst | Deletiemutant van een herpesvirus en vaccin, dat dit virus bevat. |
| USRE33772E (en) * | 1983-10-12 | 1991-12-17 | Centraal Diergeneeskundig Instituut | Deletion mutant of a herpesvirus and vaccine containing said virus |
| US4820514A (en) * | 1985-12-30 | 1989-04-11 | Texas A&M University System | Low dosage of interferon to enhance vaccine efficiency |
| US5585096A (en) * | 1994-06-23 | 1996-12-17 | Georgetown University | Replication-competent herpes simplex virus mediates destruction of neoplastic cells |
| US6471965B1 (en) * | 1994-07-27 | 2002-10-29 | Bio-Virus Research Incorporated | Vaccine containing whole killed herpes viruses to prevent development of atherosclerotic plaque |
| US5837262A (en) * | 1994-07-27 | 1998-11-17 | Bio-Virus Research Incorporated | Pharmaceutical compositions against several herpes virus infections and/or atherosclerotic plaque |
| RU2225223C1 (ru) * | 2002-06-14 | 2004-03-10 | Закрытое акционерное общество Фирма "ВИТАФАРМА" | Лиофилизированная антигерпетическая вакцина |
| EP2287288B1 (fr) * | 2002-07-09 | 2012-11-07 | Baxter International Inc. | Milieu exempt de protéines animales pour la culture de cellules |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR216081A1 (es) * | 1976-07-02 | 1979-11-30 | Dso Pharmachim | Un metodo de preparar un mutante virosico avirulento a partir del virus de aujeszky |
| DE2714665A1 (de) * | 1977-04-01 | 1978-10-05 | Mayr Anton | Praeparat zur behandlung von herpes zoster und anderen herpes-infektionen, sowie verfahren zu seiner herstellung |
-
1981
- 1981-06-06 DE DE19813122669 patent/DE3122669A1/de not_active Withdrawn
- 1981-06-08 US US06/271,106 patent/US4322404A/en not_active Expired - Fee Related
- 1981-06-10 IT IT8148649A patent/IT8148649A0/it unknown
- 1981-06-11 BE BE6/47470A patent/BE889182A/fr not_active IP Right Cessation
- 1981-06-11 ES ES502965A patent/ES502965A0/es active Granted
- 1981-06-11 NL NL8102827A patent/NL8102827A/nl not_active Application Discontinuation
- 1981-06-12 FR FR8111576A patent/FR2484446A1/fr not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| US4322404A (en) | 1982-03-30 |
| ES8303522A1 (es) | 1983-02-01 |
| FR2484446A1 (fr) | 1981-12-18 |
| DE3122669A1 (de) | 1982-02-11 |
| NL8102827A (nl) | 1982-01-04 |
| IT8148649A0 (it) | 1981-06-10 |
| ES502965A0 (es) | 1983-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE889182A (fr) | Procede de preparation de mutants nouveaux de virus d'herpes simplex type 1 ou type 2, virus mutants ainsi obtenus, vaccins prepares a partir de ceux-ci, procede pour la preparation de tels vaccins et utilisations therapeutiques et pharmacologiques | |
| OA09198A (fr) | "Comprimés de cholestyramine et procédé pour les préparer". | |
| FR2643073B1 (fr) | Procede de preparation d'extraits polyphenoliques de type flavane-3-ol purifies et extraits obtenus | |
| HUT59600A (en) | Process for producing pharmaceutical compositions containing 5-methyl-isoxazoe-4-carboxylik-anilides or alpha-/2-hydroxy-ethylidene/-alpha-cyano-acetic-anilides for treating eye-diseases | |
| FR2565231B1 (fr) | Procede de preparation d'organosilanes et d'organopolysilanes a partir d'organodisilanes | |
| FR2558166B1 (fr) | Procede de preparation d'un polymere hydrosoluble de haut poids moleculaire | |
| EP0657438A3 (fr) | Procédé pour la préparation d'alkylesulfinylbenzamides et de 1,2-benzoisothiazol-3-ones. | |
| OA07002A (fr) | Dérivé de la pyrrolidine, sa préparation et ses utilisations thérapeutiques pour le traitement de l'insuffisance cérébrale. | |
| BE883274A (fr) | Procede de preparation de xerogels de zircone et de silice, xerogels obtenus et leurs utilisations | |
| BE893492A (fr) | Procede de preparation d'esters d'acides apovincaminiques, esters ainsi obtenus et compositions pharmaceutiques prepares avec ces esters | |
| AU7394387A (en) | Sialosylcholesterol, process for its preparation, and drug for treating diseases of nervous system | |
| BE895326A (fr) | Procede de preparation d'echangeurs d'ions inorganiques a base de composes de titane, produits ainsi obtenus et leur utilisation | |
| MA20567A1 (fr) | Nouveaux derives de la thierropyridine ainsi qu'un procede pour leur preparation | |
| FR2599971B1 (fr) | Procede d'obtention de modulateurs immunologiques pour le traitement de deficiences immunitaires provoquees par des virus, et produit ainsi obtenu | |
| BE891532A (fr) | Procede de preparation d'ethyleneglycol et de ses ethers, et produits ainsi obtenus | |
| BE880732A (fr) | Procede de fabrication de vaccins contre le virus de la meningoencephalite du debut de l'ete (virus fsme) et vaccins ainsi obtenus | |
| FR2576596B1 (fr) | Procede de preparation de 4,4-dialkyl-2-azetidinones, et composes nouveaux ainsi prepares | |
| FR2606281B1 (fr) | Antigene du virus de l'hepatite b et procede pour sa production | |
| DE3666694D1 (en) | Process for producing of 4-(2-methoxyethyl)-phenylglycidyl ether and/or metoprolol | |
| FR2584418B1 (fr) | Anticorps monoclonaux contre le g-interferon, hybridomes produisant de tels anticorps, procede de preparation de tels anticorps et de tels hybridomes, leur utilisation pour differencier les gifs, et ensemble ou " kit " utilisant de tels anticorps | |
| DZ990A1 (fr) | Nouveaux dérivés du catechol ainsi qu'un procédé pour leur préparation. | |
| ATE49885T1 (de) | Avirulenter rabies-impfstoff. | |
| AU568929B2 (en) | 6-substituted prostaglandin e's and process for their preparation | |
| AU589538B2 (en) | Improved mutant vaccinia virus and process for production thereof | |
| FR2558477B1 (fr) | Procede de preparation de diphthalocyanines metalliques, produits obtenus et leur application a titre d'agents electrochromes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE | Patent lapsed |
Owner name: ASTA-WERKE A.G. CHEMISCHE FABRIK Effective date: 19840611 |